RTTNews | Nov 29, 2021 03:51PM EST

15:51 Monday, November 29, 2021 (RTTNews.com) - New Jersey-based healthcare company, Merck & Co., Inc. (MRK) saw its stock drop 6% after analysts downgrade the stock to "Neutral" from "Buy". The news came after the company published the data from its large-scale trial of Covid pills. The results showed a lower efficacy rate of the pills than was expected. This lead to Citi analysts downgrading the stock.

The stock is currently trading at $74.84, down $4.28 or 5.41% since the previous close at $79.16. The stock opened at $76.42 in the morning. In the 52-week period, the shares have ranged between $68.44 and $91.40 per share.

Read the original article on RTTNews ( https://www.rttnews.com/3245395/merck-and-co-drops-5-on-analysts-downgrading-the-stock.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved